Embedded Files
October 2025: Fall 2025 Universitas 21 International
Health Research Exchange (U21HREx) In-Person Symposium
Location: In-person at University College Dublin, Ireland with select Virtual talks and activities.
Details:
SESSIONS
Wednesday, October 15
Session 1: Opening Session on Comparative Health Systems
Session 2: Panel Session on Informing Health Policy and Practice
Thursday, October 16
Session 1: PhD Student Presentations - Quick Fire Thesis
When: 9:30-11AM GMT
Session 2: Student and Early Career Researcher Networking and Skills Development Session
When: 11:15- 12:45PM GMT (6- 7:45AM EST)
Join Virtually on Zoom | Meeting ID: 654 8459 1043, Passcode: 343267
Session 3: Student and Early Career Researcher Change Management & Health Services Implementation Workshop followed by “Ask the Experts: Common Issues and Wellness/Methods” Discussion.
When: 2:15- 4:20 PM GMT (9:15- 11:20 AM EST)
Join Virtually on Zoom | Meeting ID: 654 8459 1043, Passcode: 343267
Friday, October 17
Symposium Wrap-up: Meetings with UCD, Mater Lean Academy, Mater Misericordiae University Hospital (MMUH), and Ireland East Hospital
April 2025: Spring 2025 Universitas 21 International
Health Research Exchange (U21HREx) In-Person Symposium
Details: Join us at the University of Maryland School of Public Health to meet in-person an international team of scholars and practitioners (Ireland, Germany, USA) and learn about Health Systems Strengthening and Resilience across nations.
We have fantastic speakers presenting as part of a Panel session and individual Special Topics Seminars. We also have 2 workshops for PhD students/Early Career Researchers and MPH-MHA students.
SESSIONS
Monday April 28
Session 1: Doctoral Student and Early Career Researcher Networking and Collaboration Workshop.
Session 2: Special topics Seminar on Public Health, Tobacco Industry, & Commercial Determinants of Health
Tuesday April 29
Session 1: Special topics Seminar on the intersection of health systems strengthening, health emergencies, and health systems analysis.
Session 2: Panel Session on Health Systems Strengthening and Resilience
Session 3: Special topics Seminar on the Irish print media’s role in investigating and shaping historical Church and State abuse of women and children as national scandals.
Session 4: MPH and MHA Workshop - Change Management and Health Services Implementation
Wednesday April 30
Session 1: Special topics Seminar on the current efforts of states to transform and modernize public health systems through the lens of community engagement, information sharing, and stakeholder analysis.
Session 2: Special topics Seminar on the importance of global learning and the life-changing opportunities they present to students, early career researchers, and faculty
Details: During this session Dr. Jean Felipe Teotonio will discuss how spatial data and geographic information systems (GIS) can unlock important and actionable insights for public health decision makers in matters of chronic and communicable disease surveillance, environmental health risk and social determinants of health.
Dr. Teotonio is trained in internal medicine and healthcare quality improvement. He led the public health team at Health Solutions Research (HSR), a geospatial health analytics company, leveraging GIS and spatial data in the building of disease surveillance platforms and decision-making tools for local, state and federal health agencies as well as global health organizations.
January 2025 Talk: From Clinical Validation to Clinical Reality:
The Need for Ongoing AI safety Monitoring
Details: During this session, Dr. Adi Kale from the University of Birmingham, UK will discuss how Artificial intelligence (AI) has shown promise for use in a range of healthcare tasks such as diagnosis, prognosis, and even drug dosing.
While evidence suggests that AI can enhance or even exceed clinician accuracy in specific tasks, much of this evidence is retrospective, with limited prospective data from studies such as randomized controlled trials. Despite this, there has been an exponential increase in the number of commercially available AI-enabled medical devices. Ensuring the safety of clinical AI technologies requires rigorous post-market surveillance, a process crucial for monitoring and mitigating risks. This talk explores algorithmic auditing in addition to adverse event reporting across clinical trials and real-world settings, emphasizing the importance of post-market surveillance.
Page updated
Report abuse